CSIMarket
 


Teleflex Incorporated  (TFX)
Other Ticker:  
 
 

TFX's Capital Expenditures Growth by Quarter and Year

Teleflex Incorporated's Capital Expenditures results by quarter and year




TFX Capital Expenditures (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - 27.67 26.54 19.53
III Quarter September - 24.39 20.20 15.43
II Quarter June 34.80 17.54 19.37 17.38
I Quarter March 38.43 21.84 13.08 19.28
FY   73.23 91.44 79.19 71.62



TFX Capital Expenditures second quarter 2024 Y/Y Growth Comment
Teleflex Incorporated achieved in the second quarter 2024, above Company average Capital Expenditures rise of 98.4% year on year, to $ 34.80 millions.

Looking into second quarter 2024 results within Medical Equipment & Supplies industry 20 other companies have achieved higher Capital Expenditures growth. While Teleflex Incorporated' s Capital Expenditures jump of 98.4% ranks overall at the positon no. 400 in the second quarter 2024.




TFX Capital Expenditures ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter December - 4.26 % 35.89 % -31.06 %
III Quarter September - 20.74 % 30.91 % -33.83 %
II Quarter June 98.4 % -9.45 % 11.45 % -10.27 %
I Quarter March 75.96 % 66.97 % -32.16 % -2.03 %
FY   - 15.47 % 10.57 % -21.04 %

Financial Statements
Teleflex Incorporated's second quarter 2024 Capital Expenditures $ 34.80 millions TFX's Income Statement
Teleflex Incorporated's second quarter 2023 Capital Expenditures $ 17.54 millions Quarterly TFX's Income Statement
New: More TFX's historic Capital Expenditures Growth >>


TFX Capital Expenditures (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter December - 13.45 % 31.39 % 26.57 %
III Quarter September - 39.05 % 4.28 % -11.22 %
II Quarter June -9.45 % -19.69 % 48.09 % -9.85 %
I Quarter March 38.89 % -17.71 % -33.03 % -31.94 %
FY (Year on Year)   - 15.47 % 10.57 % -21.04 %




Capital Expenditures second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #21
Healthcare Sector #43
Overall #400

Capital Expenditures Y/Y Growth Statistics
High Average Low
100.27 % 10.95 % -48.75 %
(March 31, 2016)   (Sep. 30, 2014)
Capital Expenditures second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #21
Healthcare Sector #43
Overall #400
Capital Expenditures Y/Y Growth Statistics
High Average Low
100.27 % 10.95 % -48.75 %
(March 31, 2016)   (Sep. 30, 2014)

Capital Expenditures by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Teleflex Incorporated's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
85.66 % 1.75 % -100 %
(Jul 02 2017)  


TFX's II. Quarter Q/Q Capital Expenditures Comment
In the II. Quarter 2024 Teleflex Incorporated realized drop in Capital Expenditures sequentially by -9.45% to $ 34.80 millions, from $ 38.43 millions declared in the previous reporting period.

As we look into present slump at the II. Quarter, we must presume, that commonly II. Quarter 2024 results occur softer relative to the preciding period

Within Medical Equipment & Supplies industry 23 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Teleflex Incorporated's Capital Expenditures growth quarter on quarter, overall rank is 595.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #24
Healthcare Sector #61
Overall #595
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #24
Healthcare Sector #61
Overall #595
Capital Expenditures Q/Q Growth Statistics
High Average Low
85.66 % 1.75 % -100 %
(Jul 02 2017)  


TFX's II. Quarter Q/Q Capital Expenditures Comment
In the II. Quarter 2024 Teleflex Incorporated reported drop in Capital Expenditures from the first quarter by -9.45% to $ 34.80 millions, from $ 38.43 millions declared in the previous quarter.

As we analyse current shortcoming in the quarter, we must presume, that commonly II. Quarter Capital Expenditures emerge weaker then in the quarter before, Andrea Wolfe, market consultant mentioned.

Within Medical Equipment & Supplies industry 23 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Teleflex Incorporated's Capital Expenditures growth quarter on quarter, overall rank is 595.


Teleflex Incorporated's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Jun 30 2024)
12 Months Ending
(Mar 31 2024)
12 Months Ending
(Dec 31 2023)
12 Months Ending
(Oct 01 2023)
12 Months Ending
(Jul 02 2023)
Cumulative Capital Expenditures 12 Months Ending $ 125.30 $ 108.04 $ 91.44 $ 90.31 $ 86.12
Y / Y Capital Expenditures Growth (TTM) 45.5 % 22.85 % 15.47 % 25.12 % 27.77 %
Year on Year Capital Expenditures Growth Overall Ranking # 172 # 174 # 499 # 734 # 752
Seqeuential Capital Expenditures Change (TTM) 15.98 % 18.15 % 1.25 % 4.87 % -2.08 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 400 # 342 # 512 # 531 # 561




Cumulative Capital Expenditures growth Comment
Teleflex Incorporated saw improvement in Capital Expenditures growth trend, posting cumulative 12 months Capital Expenditures growth of 45.5% year on year, to $ 125 millions if the fiscal year would have ended in Jun 30 2024.
Teleflex Incorporated's trailing twelve months Capital Expenditures growth was higher than company's average 10.95% and higher than 22.85% growth in Mar 31 2024.
But sequential increase was beneth at 15.98 % from $108.04 millions reported in twelve months ending a quarter Mar 31 2024 Andrea Wolfe went on.
In spite of, this was validation of strength, while the usual sequential gain lays at 10.95%.
The momentum was even higher sequentially exhibited at 15.98 % rise from $108.04 millions in twelve months ending a quarter before.

Within the Healthcare sector 24 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 172, from total ranking in previous quarter at 174.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
100.27 %
10.95 %
-48.75 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 21
Healthcare Sector # 25
Overall # 172

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
100.27 %
10.95 %
-48.75 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 21
Sector # 43
S&P 500 # 400
Cumulative Capital Expenditures growth Comment
Teleflex Incorporated saw improvement in Capital Expenditures growth trend, posting cumulative 12 months Capital Expenditures growth of 45.5% year on year, to $ 125 millions if the fiscal year would have ended in Jun 30 2024.
Teleflex Incorporated's trailing twelve months Capital Expenditures growth was higher than company's average 10.95% and higher than 22.85% growth in Mar 31 2024.
But from the previous reporting period rise was less at 15.98 % from $108.04 millions recorded in the period from Mar 31 2024 to Jul 02 2023.
Yet it was evidence of strength, while the typical sequential Capital Expenditures gain stands at 10.95%.
The progress was even higher from twelve months ended Mar 31 2024 clinched at 15.98 % increase from $108.04 millions in the period from Mar 31 2024 to Jul 02 2023.

Within the Healthcare sector 24 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 172, from total ranking in previous quarter at 174.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
100.27 %
10.95 %
-48.75 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 21
Healthcare Sector # 25
Overall # 172

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
100.27 %
10.95 %
-48.75 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 21
Sector # 43
S&P 500 # 400




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
TFX's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for TFX's Competitors
Capital Expenditures Growth for Teleflex Incorporated's Suppliers
Capital Expenditures Growth for TFX's Customers

You may also want to know
TFX's Annual Growth Rates TFX's Profitability Ratios TFX's Asset Turnover Ratio TFX's Dividend Growth
TFX's Roe TFX's Valuation Ratios TFX's Financial Strength Ratios TFX's Dividend Payout Ratio
TFX's Roa TFX's Inventory Turnover Ratio TFX's Growth Rates TFX's Dividend Comparisons



Companies with similar Capital Expenditures drop for the quarter ending Jun 30 2024 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Jun 30 2024
Adma Biologics Inc 171.02%$ 171.019 millions
Editas Medicine Inc 162.12%$ 162.116 millions
Inspire Medical Systems inc 155.26%$ 155.263 millions
Bausch Health Companies Inc 154.84%$ 154.839 millions
Delcath Systems Inc 152.50%$ 152.500 millions
Cvrx inc 148.25%$ 148.252 millions
Bionano Genomics Inc 140.63%$ 140.625 millions
Bausch and Lomb Corp140.00%$ 140.000 millions
Roivant Sciences Ltd 139.45%$ 139.454 millions
Cardio Diagnostics Holdings Inc 129.53%$ 129.533 millions
125.74%$ 125.737 millions
Catheter Precision Inc 125.00%$ 125.000 millions
Structure Therapeutics Inc 123.56%$ 123.560 millions
Silk Road Medical Inc 119.82%$ 119.816 millions
Precipio inc 118.75%$ 118.750 millions
Lantheus Holdings Inc 117.84%$ 117.838 millions
Livanova Plc114.81%$ 114.808 millions
Rapid Micro Biosystems Inc 113.49%$ 113.488 millions
Veru Inc 112.78%$ 112.783 millions
Artivion Inc 111.89%$ 111.889 millions
Pliant Therapeutics Inc 107.46%$ 107.463 millions
Ligand Pharmaceuticals Incorporated100.99%$ 100.985 millions
Elicio Therapeutics Inc 100.00%$ 100.000 millions
Ginkgo Bioworks Holdings Inc 99.75%$ 99.749 millions
Vanda Pharmaceuticals Inc 96.36%$ 96.364 millions
The Oncology Institute Inc 94.88%$ 94.877 millions
Integra Lifesciences Holdings Corp91.07%$ 91.066 millions
Tela Bio Inc 90.45%$ 90.446 millions
Infusystem Holdings Inc90.40%$ 90.395 millions
Radnet Inc 89.17%$ 89.174 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com